Mild Hypothermia Influence on Patient Outcome in Major Abdominal Surgery

June 19, 2020 updated by: Haukeland University Hospital

Does Mild Hypothermia Increase Intra-Operative Blood Loss and Surgical Site Infections in Major Abdominal Surgery?

This study investigate associations between mild hypothermia (patients' core temperature ≤ 36.0 degrees Celsius) and intra-operative blood loss and surgical site infections (SSI) in patients undergoing major abdominal surgery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study evaluates associations between patients' core temperature during surgery and intra-operative blood loss, and to SSI. Additionally, the investigators observe the use of hypothermia prevention measures in operating theaters, use of surgical safety checklists. SSI is registered at discharge from hospital and up to 30 days post-discharge.

The goal of the study is to contribute to focus on prevention of even mild hypothermia in surgery.

This study is of interest for healthcare personnel as operating room nurses, surgeons, nurse anaesthetists, anaesthesiologists, ward nurses, post anaesthetic care unit nurses, and other healthcare staff involved in the in-hospital surgical pathway.

Study Type

Observational

Enrollment (Actual)

3059

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bergen, Norway, 5021
        • Haukeland University Hospital
    • Hordaland
      • Bergen, Hordaland, Norway, 5021
        • Haukeland University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population consist of patients undergoing abdominal or gynecologic laparatomy or laparoscopy in a tertiary teaching hospital in Norway.

Description

Inclusion Criteria:

  • Patients (men or women) above 18 years, undergoing abdominal or gynecological surgery with laparotomy or laparoscopy.

Exclusion Criteria:

  • Surgical procedures with intentional reduction of core temperature. Patients under the age of 18.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hypothermia
Patients with mild hypothermia at start of the surgery
Patients are routinely warmed with forced air warming blankets, regular blankets, pre warmed intravenous fluid. Routines are ensured with use of the WHO Surgical Safety Checklist. The intervention is the use of operating theatre care measures to prevent mild hypothermia in surgical patients.
Other Names:
  • Forced air warming blankets
Normothermia
Patients with normal core temperature at start of surgery.
Patients are routinely warmed with forced air warming blankets, regular blankets, pre warmed intravenous fluid. Routines are ensured with use of the WHO Surgical Safety Checklist. The intervention is the use of operating theatre care measures to prevent mild hypothermia in surgical patients.
Other Names:
  • Forced air warming blankets

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra-operative blood loss (mL) in surgical patients
Time Frame: Within the surgical procedure
Bleeding that occur during the surgical procedure
Within the surgical procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peri-operative blood loss (registered by ICD-10 codes)
Time Frame: Within the duration of the surgical procedures, an average of 2.5 hours
Bleeding requiring blood transfusion peri-operatively
Within the duration of the surgical procedures, an average of 2.5 hours
Number of patients with Surgical Site Infections after surgery
Time Frame: Up to 30 days after discharge from hospital
Post-operative surgical site infections present before discharge from hospital
Up to 30 days after discharge from hospital
Number of patients with Surgical Site Infection
Time Frame: Up to 30 days after discharge from hospital
Post-operative surgical site infection present after discharge from hospital
Up to 30 days after discharge from hospital
Days admitted in hospital
Time Frame: Hospital stay up to 13 days on average
Length of stay in hospital
Hospital stay up to 13 days on average
Hours admitted in post operative care unit (PACU)
Time Frame: On average up to 14 hours
Length of stay in PACU
On average up to 14 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arvid S Haugen, PhD, MSc, Haukeland University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

March 26, 2017

First Submitted That Met QC Criteria

April 7, 2017

First Posted (Actual)

April 13, 2017

Study Record Updates

Last Update Posted (Actual)

June 23, 2020

Last Update Submitted That Met QC Criteria

June 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Anonymous individual data is allowed to share, thought such request must be approved by the REK West. Data will be available from the primary investigator.

Study Data/Documents

  1. Study Protocol
    Information identifier: REC West (2016-2193)
    Information comments: Study protocol is available on request to Regional Committees for Medical and Health Research Ethics.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bleeding

Clinical Trials on Prevention of hypothermia

Subscribe